<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://thevitalrecord.ai/2026/06/15/nara-organics-botulism-recall/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T00:00:00.000Z</news:publication_date>
      <news:title>FDA and CDC Investigate Nationwide Voluntary Recall of Nara Organics Powdered Infant Formula After Three Infants Hospitalized With Botulism</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/15/nara-organics-recall-when-epidemiology-outruns-the-lab/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T00:00:00.000Z</news:publication_date>
      <news:title>The Nara Organics Recall: When Epidemiology Must Move Faster Than the Lab</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/15/oceanic-af-asundexian-termination/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T00:00:00.000Z</news:publication_date>
      <news:title>OCEANIC-AF Stopped Early for Inferior Efficacy After 14,830 Patients: What the Failure of This FXIa Inhibitor Means for Anticoagulation Research</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/15/pph-lancet-series/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T00:00:00.000Z</news:publication_date>
      <news:title>A Woman Dies of Postpartum Haemorrhage Every 12 Minutes. A Landmark Lancet Series Charts Why So Many Cases Are Still Being Missed — and What Must Change.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/15/intellia-lonvo-z-haelo-phase3/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T00:00:00.000Z</news:publication_date>
      <news:title>Single-Dose Investigational CRISPR Therapy Cut HAE Attacks 87% in Phase 3 HAELO Trial, Company Reports</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/15/llm-vs-clinical-ai-nature-medicine/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T00:00:00.000Z</news:publication_date>
      <news:title>General-Purpose AI Outperforms Specialized Clinical Tools in Head-to-Head Benchmark</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/15/empact-mi-empagliflozin-post-mi/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T00:00:00.000Z</news:publication_date>
      <news:title>EMPACT-MI: Empagliflozin Falls Short on Primary Endpoint After Acute Heart Attack</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/15/arpa-h-advocate-agentic-ai-cardiology/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T00:00:00.000Z</news:publication_date>
      <news:title>ARPA-H Launches ADVOCATE to Fund Development of the First FDA-Authorized Autonomous AI System for Cardiovascular Care</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/15/rad51d-xrcc2-saturation-genome-editing/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-15T00:00:00.000Z</news:publication_date>
      <news:title>PREPRINT — NOT PEER REVIEWED: Saturation Genome Editing Characterizes Nearly All Variants in Two Cancer-Risk Genes, Supporting Future Clinical Classification</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/14/bundibugyo-ebola-don607/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-14T00:00:00.000Z</news:publication_date>
      <news:title>Bundibugyo Ebola Outbreak Reaches 695 Confirmed Cases as DRC and Uganda Battle Virus With No Approved Vaccine</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/14/a-race-against-a-virus-we-have-no-licensed-weapon-to-fight/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-14T00:00:00.000Z</news:publication_date>
      <news:title>A Race Against a Virus We Have No Licensed Weapon to Fight</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/14/gastric-picu-rct-jama/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-14T00:00:00.000Z</news:publication_date>
      <news:title>Skipping Routine Gastric Checks Is Noninferior to Standard Monitoring in Critically Ill Children, Large RCT Finds</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/14/cerepak-coil-class-i-recall/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-14T00:00:00.000Z</news:publication_date>
      <news:title>FDA Classifies J&amp;J Cerenovus Brain Coil Recall as Class I After Patient Death and Four Injuries</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/14/nws-cdc-eoc-texas-nm/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-14T00:00:00.000Z</news:publication_date>
      <news:title>CDC Opens Emergency Operations Center as Screwworm Infestations Spread Across Texas and New Mexico</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/14/pramipexole-anhedonia-rct/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-14T00:00:00.000Z</news:publication_date>
      <news:title>A Small Placebo-Controlled Trial Links Pramipexole to Reduced Anhedonia in Mood Disorders</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/14/bd-chloraprep-aspergillus-recall/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-14T00:00:00.000Z</news:publication_date>
      <news:title>BD Recalls Two Lots of ChloraPrep and FREPP Skin-Prep Applicators Over Aspergillus Fungal Contamination</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/14/zenith-zilebesiran-phase3-launch/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-14T00:00:00.000Z</news:publication_date>
      <news:title>Investigational RNA Drug Zilebesiran Enters Phase 3 MACE Trial in 11,000 Patients With Uncontrolled Hypertension</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/14/pathorob-pathology-ai-robustness/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-14T00:00:00.000Z</news:publication_date>
      <news:title>AI Pathology Models Pass Lab Tests But Stumble Across Hospitals, New Benchmark Finds</news:title>
    </news:news>
  </url>
</urlset>
